Astrana Health Inc (ASTH)
55.92
+1.62
(+2.98%)
USD |
NASDAQ |
Nov 05, 16:00
55.92
0.00 (0.00%)
After-Hours: 19:03
Astrana Health Net Income (Quarterly): 19.17M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.17M |
| March 31, 2024 | 14.84M |
| December 31, 2023 | 12.36M |
| September 30, 2023 | 22.06M |
| June 30, 2023 | 13.17M |
| March 31, 2023 | 13.13M |
| December 31, 2022 | -3.728M |
| September 30, 2022 | 23.18M |
| June 30, 2022 | 11.95M |
| March 31, 2022 | 13.76M |
| December 31, 2021 | 8.835M |
| September 30, 2021 | 34.28M |
| June 30, 2021 | 12.66M |
| March 31, 2021 | 13.15M |
| December 31, 2020 | -51.56M |
| September 30, 2020 | 16.71M |
| June 30, 2020 | 7.044M |
| March 31, 2020 | 4.052M |
| December 31, 2019 | 6.727M |
| September 30, 2019 | 3.704M |
| June 30, 2019 | 3.545M |
| March 31, 2019 | 0.14M |
| December 31, 2018 | -3.096M |
| September 30, 2018 | 9.106M |
| June 30, 2018 | 2.664M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.160M |
| September 30, 2017 | -3.883M |
| June 30, 2017 | -3.612M |
| March 31, 2017 | -4.563M |
| December 31, 2016 | -1.733M |
| September 30, 2016 | -1.358M |
| June 30, 2016 | -1.315M |
| March 31, 2016 | -4.645M |
| December 31, 2015 | -1.686M |
| September 30, 2015 | -0.5314M |
| June 30, 2015 | -2.482M |
| March 31, 2015 | 0.1904M |
| December 31, 2014 | -1.692M |
| September 30, 2014 | 1.376M |
| June 30, 2014 | -1.678M |
| January 31, 2014 | -1.624M |
| October 31, 2013 | -1.015M |
| July 31, 2013 | -1.532M |
| April 30, 2013 | -0.8491M |
| January 31, 2013 | -0.823M |
| October 31, 2012 | -4.721M |
| July 31, 2012 | -3.203M |
| April 30, 2012 | -0.1574M |
| January 31, 2012 | -0.4268M |
| October 31, 2011 | 0.0582M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-51.56M
Minimum
Dec 2020
34.28M
Maximum
Sep 2021
10.09M
Average
13.13M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
| Evolent Health Inc | 1.596M |
| American Shared Hospital Services | 3.602M |
| Novo Integrated Sciences Inc | -13.74M |
| Cryo-Cell International Inc | 1.052M |
| P3 Health Partners Inc | -12.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 486.26M |
| Total Expenses (Quarterly) | 456.20M |
| EPS Diluted (Quarterly) | 0.40 |
| Enterprise Value | 2.392B |
| Gross Profit Margin (Quarterly) | 15.11% |
| Profit Margin (Quarterly) | 3.94% |
| Earnings Yield | 2.58% |
| Operating Earnings Yield | 3.60% |
| Normalized Earnings Yield | 2.520 |